RCGE - ETF AI Analysis

Top Page

RockCreek Global Equality ETF (RCGE)

Rating:60Neutral

Price Target:―

The RockCreek Global Equality ETF (RCGE) has a balanced overall rating, driven by strong contributions from holdings like Merck & Company and Expedia. Merck stands out for its robust financial performance and growth potential, while Expedia benefits from strong earnings and strategic initiatives. However, weaker performers like Bayer and VF Corporation, which face financial challenges and valuation concerns, slightly weigh down the fund's overall score. A key risk factor is the ETF's exposure to companies with high leverage and cash flow issues, which could impact stability during market downturns.

Positive Factors

Strong Year-to-Date Performance

The ETF has delivered solid returns so far this year, indicating strong overall performance.

Global Diversification

The fund invests in companies across multiple countries, reducing reliance on any single geographic region.

Exposure to Stable Sectors

The ETF includes significant allocations to traditionally stable sectors like Financials and Health Care.

Negative Factors

High Expense Ratio

The ETF charges a relatively high fee, which could eat into investor returns over time.

Underperforming Holdings

Some top holdings, such as Charles River Labs and Land Securities Group, have shown weaker year-to-date performance.

Limited Emerging Market Exposure

The fund has minimal exposure to emerging markets, potentially missing out on higher-growth opportunities.

RCGE vs. SPDR S&P 500 ETF (SPY)

AUM86.97M

RegionGlobal

Expense Ratio0.95%

Beta0.66

IssuerRockCreek

Inception DateFeb 26, 2025

Dividend Yield1.8%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume14

30 Day Avg. Volume6,642

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

31.40

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering189

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

RCGE Summary

The RockCreek Global Equality ETF (RCGE) is an actively managed fund that invests in large companies worldwide, focusing on those committed to gender equality in their corporate structures. It includes well-known firms like Johnson & Johnson and Exelon, offering exposure to industries such as healthcare, financials, and technology. This ETF is ideal for investors who want to align their investments with social values while aiming for growth and diversification. However, new investors should note that the fund’s performance can fluctuate with the broader market, and its focus on gender-balanced companies may limit exposure to other potentially high-performing firms.

How much will it cost me?The RockCreek Global Equality ETF (RCGE) has an expense ratio of 0.95%, which means you’ll pay $9.50 per year for every $1,000 invested. This is higher than average because it’s an actively managed fund, requiring more research and oversight compared to passively managed ETFs that track an index.

What would affect this ETF?The RockCreek Global Equality ETF (RCGE) could benefit from growing global interest in socially responsible investing and corporate diversity, as well as potential economic growth in both developed and emerging markets. However, it may face challenges from rising interest rates, which could impact sectors like real estate and financials, or economic slowdowns that affect large-cap companies globally. Additionally, its focus on gender equality may limit its investment universe, potentially reducing diversification compared to broader ETFs.

RCGE Top 10 Holdings

The RockCreek Global Equality ETF is leaning heavily on financials, with names like NatWest Group and Standard Chartered driving steady performance thanks to strong earnings and strategic initiatives. Bayer and Merck, representing healthcare, are showing mixed results—Merck’s pipeline advancements are promising, but Bayer’s financial challenges are holding it back. VF Corporation from consumer cyclical is lagging, weighed down by financial struggles despite some strategic moves. With a global mix of holdings and a focus on large-cap stability, the fund’s sector diversity offers resilience, though financials are clearly steering the ship.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
	―	1.63%	$1.41M	―	―	―
GM	General Motors	0.69%	$595.74K	$77.48B	53.02%	73 Outperform
ENRG	Energix	0.68%	$592.39K	8.99B	33.15%	59 Neutral
MRK	Merck & Company	0.64%	$560.78K	$265.03B	7.10%	80 Outperform
BAYN	Bayer	0.64%	$554.49K	€35.31B	87.92%	54 Neutral
CRL	Charles River Labs	0.63%	$551.99K	$10.02B	9.40%	60 Neutral
4503	Astellas Pharma	0.63%	$548.06K	¥3.78T	36.83%	69 Neutral
EXPE	Expedia	0.62%	$542.19K	$35.24B	54.51%	80 Outperform
NWG	NatWest Group	0.61%	$534.06K	£51.71B	61.54%	75 Outperform
STAN	Standard Chartered	0.61%	$529.15K	£40.86B	100.92%	77 Outperform

RCGE Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

27.52

Positive

100DMA

27.36

Positive

200DMA

26.31

Positive

Market Momentum

MACD

0.26

Negative

RSI

70.17

Negative

STOCH

12.59

Positive

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RCGE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 27.88, equal to the 50-day MA of 27.52, and equal to the 200-day MA of 26.31, indicating a bullish trend. The MACD of 0.26 indicates Negative momentum. The RSI at 70.17 is Negative, neither overbought nor oversold. The STOCH value of 12.59 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RCGE.

RCGE Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
RCGE	―	―	$86.97M	0.95%	―
GINX	―	―	$79.18M	0.99%	―
GPT	―	―	$22.16M	0.69%	―
NBGX	―	―	$13.41M	0.44%	―
FFLV	―	―	$12.32M	0.38%	―
JDIV	―	―	$9.40M	0.47%	―

Performance Comparison

RCGE

RockCreek Global Equality ETF

28.40

4.24

17.55%

GINX

SGI Enhanced Global Income ETF

―

GPT

Intelligent Alpha Atlas ETF

―

NBGX

Neuberger Berman Growth ETF

―

FFLV

Fidelity Fundamental Large Cap Value ETF

―

JDIV

JPMorgan Dividend Leaders ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents